Regulation: The FDA is overcautious on consumer genomics

作者: Robert C Green , Nita A Farahany

DOI: 10.1038/505286A

关键词: Political scienceLawHarmGenomicsMultidisciplinary

摘要: A US drug-agency clampdown is unwarranted without evidence of harm, say Robert C. Green and Nita A. Farahany.

参考文章(7)
Melanie Swan, Multigenic condition risk assessment in direct-to-consumer genomic services Genetics in Medicine. ,vol. 12, pp. 279- 288 ,(2010) , 10.1097/GIM.0B013E3181D5F73B
Robert C. Green, J. Scott Roberts, L. Adrienne Cupples, Norman R. Relkin, Peter J. Whitehouse, Tamsen Brown, Susan LaRusse Eckert, Melissa Butson, A. Dessa Sadovnick, Kimberly A. Quaid, Clara Chen, Robert Cook-Deegan, Lindsay A. Farrer, Disclosure of APOE Genotype for Risk of Alzheimer's Disease The New England Journal of Medicine. ,vol. 361, pp. 245- 254 ,(2009) , 10.1056/NEJMOA0809578
Cinnamon S Bloss, Laura Ornowski, Elana Silver, Michele Cargill, Vance Vanier, Nicholas J Schork, Eric J Topol, Consumer perceptions of direct-to-consumer personalized genomic risk assessments Genetics in Medicine. ,vol. 12, pp. 556- 566 ,(2010) , 10.1097/GIM.0B013E3181EB51C6
Rachel R.J. Kalf, Raluca Mihaescu, Suman Kundu, Peter de Knijff, Robert C. Green, A. Cecile J.W. Janssens, Variations in predicted risks in personal genome testing for common complex diseases Genetics in Medicine. ,vol. 16, pp. 85- 91 ,(2014) , 10.1038/GIM.2013.80
David J. Kaufman, Juli M. Bollinger, Rachel L. Dvoskin, Joan A. Scott, Risky Business: Risk Perception and the Use of Medical Services among Customers of DTC Personal Genetic Testing Journal of Genetic Counseling. ,vol. 21, pp. 413- 422 ,(2012) , 10.1007/S10897-012-9483-0
Uta Francke, Cheri Dijamco, Amy K. Kiefer, Nicholas Eriksson, Bianca Moiseff, Joyce Y. Tung, Joanna L. Mountain, Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing PeerJ. ,vol. 1, ,(2013) , 10.7717/PEERJ.8
Phyllis J. Fawcett, The Creative Destruction of Medicine AORN Journal. ,vol. 97, pp. 760- 761 ,(2013) , 10.1016/J.AORN.2013.03.012